effect
differ
rout
immun
either
live
kill
bovin
rotaviru
brv
product
lactogen
antibodi
respons
mice
evalu
rout
immun
intramuscular
im
oral
intraderm
mammari
region
imam
follow
immun
serum
antibodi
respons
monitor
enzym
link
immunosorb
assay
elisa
follow
whelp
mice
allow
stay
mother
sacrif
altern
day
postparturit
day
milk
stomach
collect
antibodi
titrat
elisa
viru
neutral
test
regardless
rout
immun
rapid
increas
serum
antirotaviru
antibodi
titer
observ
first
wk
immun
follow
gradual
declin
parturit
mean
antibodi
titer
lacteal
secret
determin
elisa
increas
gradual
day
greatest
increas
day
follow
decreas
antirotaviru
antibodi
titer
also
correl
antibodi
titer
milk
measur
viru
neutral
test
best
lactogen
antibodi
respons
observ
imam
x
im
x
rout
immun
use
live
brv
antigen
interestingli
immun
via
oral
rout
kill
brv
also
result
good
antibodi
respons
contrast
group
kill
brv
use
anim
receiv
oral
highest
antibodi
titer
distribut
differ
antibodi
subtyp
milk
sampl
reveal
igg
predomin
antibodi
follow
igm
iga
rotaviru
identifi
singl
import
caus
agent
acut
neonat
enter
varieti
domest
laboratori
anim
human
consequ
worldwid
effort
made
develop
appropri
vaccin
pathogen
babiuk
et
al
flewett
babiuk
hanson
et
al
although
previou
studi
indic
correl
protect
rotaviru
infect
titer
passiv
acquir
antibodi
serum
newborn
saif
smith
mk
ijaz
et
al
unpublish
data
shown
continu
presenc
antirotaviru
antibodi
intestin
neonat
import
prevent
clinic
diseas
associ
rotaviru
infect
offit
clark
saif
smith
snodgrass
et
al
mk
ijaz
et
al
unpublish
data
sever
anim
speci
includ
human
immun
pregnanc
shown
result
presenc
antibodi
colostrum
milk
goldblum
et
al
saif
smith
addit
humor
immun
respons
role
play
cellular
compon
immun
product
lactogen
immun
respons
also
document
parmerli
beer
ripenhofftalti
et
al
cell
transfer
experi
mice
reveal
migrat
lymphoblast
mesenter
lymph
node
intestin
mammari
gland
secretori
organ
peripher
lymph
node
mcdermott
et
al
mcdowel
lascel
cell
migrat
secretori
organ
mesenter
lymph
node
synthes
iga
migrat
peripher
lymph
node
produc
igg
igm
bohl
et
al
mcdermott
et
al
roux
et
al
experi
carri
porcin
bovin
model
reveal
predomin
iga
igg
subtyp
porcin
bovin
milk
respect
decreas
subtyp
occur
postparturit
period
saif
bohl
saif
smith
thu
becom
imper
direct
effort
order
stimul
lactogen
antirotaviru
antibodi
respons
higher
titer
longer
period
parturit
ensur
protect
rotaviru
infect
neonat
receiv
antibodi
mother
milk
earlier
experi
conduct
determin
kinet
brv
replic
mous
model
reveal
neonat
suscept
infect
age
seven
day
ijaz
et
al
prepar
protect
studi
neonat
challeng
day
seven
take
consider
util
murin
model
studi
influenc
differ
rout
immun
either
live
kill
brv
rate
declin
antibodi
titer
differ
subtyp
lacteal
secret
dam
follow
parturit
eleven
day
report
form
basi
protect
studi
current
way
rotavirusfre
mice
obtain
charl
river
breed
laboratori
wilmington
order
ensur
free
antirotaviru
antibodi
bled
arriv
coccigi
vein
sera
test
antirotaviru
antibodi
use
elisa
assay
bidwel
et
al
found
seroneg
maintain
rotaviru
free
anim
hous
isol
unit
throughout
experi
bovin
rotaviru
brv
isol
grown
cell
presenc
pg
trypsinml
difco
laboratori
detroit
mi
babiuk
et
al
h
incub
supernat
contain
viru
harvest
cell
debri
remov
centrifug
rpm
min
viru
concentr
clarifi
supernat
fluid
pellet
sucros
cushion
rpm
rotor
beckman
model
h
viru
pellet
resuspend
doubl
distil
water
amount
viru
protein
measur
spectophotometr
use
formula
alj
zho
x
kgml
repres
adsorb
nm
nm
respect
live
brv
use
antigen
dam
given
lrg
x
lo
plaqu
form
unit
purifi
viru
contain
adjuv
freund
incomplet
adjuv
fia
doubl
distil
water
accord
immun
protocol
tabl
kill
brv
prepar
describ
order
inactiv
viru
subject
ultraviolet
light
erg
h
extent
inactiv
test
vitro
instanc
activ
bovin
rotaviru
found
inactiv
procedur
dam
given
kg
purifi
viru
contain
adjuv
doubl
distil
water
accord
immun
protocol
tabl
oral
immun
mice
inocul
kg
brv
follow
wk
later
viral
dose
inocul
oral
one
week
final
booster
inocul
mice
bred
femaletomal
ratio
l
dam
gave
birth
natur
pup
remain
dam
throughout
experi
sampl
sampl
process
mice
bled
prior
immun
sera
test
presenc
rotaviru
antibodi
elisa
viru
neutral
test
mice
seroneg
rotaviru
initi
studi
thereaft
blood
sampl
taken
weekli
cours
immun
monitor
antibodi
respons
indic
immun
protocol
tabl
immun
interv
chosen
arbitrarili
three
week
sinc
instanc
maxim
immun
occur
three
week
postvaccin
newborn
mice
allow
stay
mother
throughout
period
experi
order
collect
sampl
colostrum
milk
three
neonat
group
sacrif
everi
second
day
post
parturit
start
day
milk
stomach
collect
dilut
twofold
mem
sampl
spun
eppendorf
centrifug
supernat
aliquot
eppendorf
tube
store
enzymelitlk
ittmutosorhetr
rrssup
elisa
detectiotl
irotaviru
antibodi
antibodi
level
serum
milk
sampl
brv
determin
method
describ
previous
bidwel
et
al
briefli
microtit
plate
immunolon
dynatech
laboratori
inc
alexandria
va
incub
overnight
fg
brv
isol
antigen
dilut
x
carbonatebicarbon
ph
volum
brv
per
well
incub
plate
antigen
unadsorb
protein
remov
extens
wash
distil
water
antigen
overlaid
mous
antiserum
per
well
undilut
form
dilut
phosphatebuff
salin
contain
fetal
bovin
serum
fb
incub
antigen
carri
h
room
temperatur
time
unbound
antibodi
remov
wash
distil
water
dilut
rabbit
antimous
horseradish
peroxidas
conjug
boehring
mannheim
biochem
calgari
alberta
ad
per
well
incub
conjug
proceed
room
temperatur
addit
hour
extens
wash
remov
excess
conjug
bound
conjug
react
chromagen
enzym
substrat
recrystal
salicycl
acid
mgml
phosphat
buffer
ph
aldrich
chemic
co
milwauke
wn
per
well
cc
hydrogen
peroxid
ad
immedi
use
reaction
allow
proceed
min
room
temperatur
absorb
nm
well
determin
microelisa
reader
dynatech
instrument
inc
ca
titer
express
reciproc
highest
dilut
od
sd
mean
background
level
quantit
differ
class
antibodi
mous
milk
mous
monoclon
subtyp
kit
use
follow
procedur
recommend
manufactur
hyclon
laboratori
logan
ut
microtieiwalizutiotl
test
neutral
brv
milk
sampl
taken
hyperimmun
dam
determin
microneutr
test
use
plate
contain
confluent
monolay
cell
grown
eagl
minim
essenti
media
mem
fb
gibco
laboratori
grand
island
ny
milk
sampl
serial
dilut
incub
min
viru
dilut
repres
ad
l
variou
dilut
milk
virusmilk
mixtur
transfer
plate
contain
confluent
monolay
cell
well
duplic
plate
contain
virusmilk
mixtur
incub
h
cell
monolay
wash
mem
replac
mem
plate
incub
two
day
dilut
sampl
give
cytopath
effect
cpe
observ
microscop
taken
end
point
sinc
passiv
protect
import
prevent
rotaviru
infect
neonat
import
neonat
receiv
suffici
quantiti
neutral
antibodi
milk
mother
studi
interest
determin
best
regimen
immun
brv
would
result
highest
neutral
antibodi
level
milk
achiev
goal
mice
immun
either
live
kill
brv
via
differ
rout
level
serum
antibodi
rotaviru
monitor
throughout
immun
schedul
parturit
parturit
antirotaviru
antibodi
determin
lacteal
secret
day
use
elisa
viru
neutral
test
antibodi
titer
serum
colostrum
milk
shown
fig
milk
sampl
also
examin
determin
differ
immunoglobulin
ig
class
data
show
ratio
variou
subtyp
milk
collect
dam
immun
either
live
kill
brv
summar
tabl
distribut
differ
subtyp
milk
sampl
reveal
igg
predomin
antibodi
follow
igm
iga
interest
note
regardless
rout
immun
gradual
increas
antibodi
titer
lacteal
secret
observ
day
postpartum
greatest
increas
day
follow
decreas
titer
day
uniqu
observ
compar
speci
ltntnunizatiotz
kill
bovirl
rotavirm
determin
whether
kill
brv
produc
lactogen
antirotaviru
antibodi
respons
experi
perform
use
antigen
oral
combin
rout
anim
immun
follow
rout
use
kill
brv
x
x
im
x
im
x
imam
x
freund
complet
adjuv
fca
freund
incomplet
adjuv
fia
use
im
rout
immun
tabl
immun
kill
brv
significantli
increas
antirotaviru
antibodi
serum
group
regardless
rout
immun
fig
rapid
immun
respons
observ
week
first
immun
compar
almost
neglig
titer
day
reflect
anim
prime
immun
mice
use
studi
pretest
antirotaviru
antibodi
found
seroneg
control
mice
remain
seroneg
throughout
studi
howev
show
rotaviru
highli
immunogen
among
group
immun
kill
brv
group
immun
time
via
imam
rout
show
best
antirotaviru
serum
antibodi
respons
interest
unexplain
decreas
antibodi
occur
day
postimmun
anim
immun
via
imam
rout
fig
howev
second
immun
day
increas
antibodi
titer
group
although
second
immun
boost
antibodi
titer
group
third
immun
day
show
effect
level
antibodi
product
group
studi
fig
antibodi
titer
rotaviru
lacteal
secret
determin
elisa
vari
log
group
one
day
postparturit
fig
anim
immun
x
highest
titer
wherea
im
x
lowest
antibodi
titer
gradual
increas
antibodi
observ
group
maximum
antibodi
titer
lacteal
secret
achiev
day
parturit
unlik
serum
antibodi
highest
lacteal
antibodi
titer
occur
group
immun
x
x
im
x
viru
neutral
antibodi
titer
milk
show
similar
pattern
throughout
lactat
elisa
titer
howev
antirotaviru
antibodi
titer
determin
elisa
consist
higher
viru
neutral
titer
except
group
immun
x
show
slightli
higher
neutral
titer
day
parturit
fig
immun
live
bovin
rotaviru
sinc
kill
antigen
produc
excel
respons
follow
oral
immun
attempt
made
similar
studi
live
viru
anim
immun
follow
rout
use
live
brv
x
x
im
x
im
x
imam
x
imam
x
im
x
without
adjuv
indic
immun
schedul
tabl
immun
live
brv
induc
product
high
level
antirotaviru
antibodi
serum
dam
group
pattern
immun
respons
rapid
similar
group
immun
kill
brv
one
except
group
immun
imam
x
im
x
reveal
significantli
higher
antia
rotaviru
antibodi
day
primari
immun
wk
second
immun
rapid
decreas
antibodi
titer
particular
group
day
first
immun
second
immun
day
induc
higher
level
antibodi
rest
group
third
immun
day
increas
antibodi
product
antibodi
level
serum
start
declin
toward
time
parturit
fig
titer
antirotaviru
antibodi
lacteal
secret
determin
elisa
also
reveal
similar
pattern
seen
group
immun
kill
brv
colostrum
milk
sampl
collect
week
parturit
show
gradual
increas
antibodi
titer
determin
elisa
highest
antirotaviru
antibodi
titer
group
observ
day
postparturit
maximum
titer
antibodi
point
observ
group
immun
imam
x
im
x
titer
start
declin
thereaft
fig
viru
neutral
antibodi
titer
lacteal
secret
exhibit
similar
pattern
throughout
lactat
antirotaviru
antibodi
titer
determin
elisa
consist
higher
viru
neutral
antibodi
titer
group
fig
distribut
antibodi
associ
variou
immunoglobulin
ig
subtyp
mammari
secret
present
tabl
throughout
durat
experi
igg
antibodi
predomin
follow
igm
iga
group
irrespect
rout
immun
type
antigen
use
gradual
reduct
distribut
igg
igm
antibodi
end
experi
contrast
iga
antibodi
gradual
decreas
day
postparturit
show
increas
day
decreas
sinc
neonat
often
expos
enter
virus
suffici
time
develop
activ
immun
highli
suscept
infect
unless
passiv
immun
exposur
pathogen
lactogen
immun
shown
play
major
role
provid
protect
neonat
varieti
mammalian
speci
enter
infect
hanson
et
al
knight
peaker
offit
clark
opdebeeck
underlin
signific
passiv
requir
antibodi
colostrum
milk
neonat
gut
prevent
infect
hanson
et
al
therefor
consider
effort
underway
order
develop
vaccin
stimul
lactogen
immun
enter
infect
order
improv
immun
statu
neonat
therebi
prevent
earli
infect
babiuk
et
al
role
matern
antibodi
protect
neonat
diarrhea
caus
number
viral
agent
shown
depend
continu
presenc
antibodi
intestin
lumen
saif
smith
case
rotaviru
induc
neonat
diarrhea
calv
lamb
experiment
shown
feed
colostrum
milk
serum
contain
suffcient
antirotaviru
antibodi
infect
intestin
prevent
snodgrass
et
al
degre
protect
correl
quantiti
antirotaviru
antibodi
present
also
subtyp
ig
involv
snodgrass
et
al
local
immun
rotaviru
perform
two
function
first
presenc
antibodi
intestin
protect
neonat
diseas
secondli
help
reduct
rotaviru
fece
henc
reduc
environment
contamin
saif
smith
sinc
mous
model
use
protectivechalleng
experi
rotaviru
infect
util
neonat
day
age
time
mous
enterocyt
highest
number
rotaviru
specif
receptor
therebi
make
suscept
infect
riepenhofftalti
et
al
studi
lacteal
antibodi
respons
span
time
frame
plu
day
beyond
achiev
differ
rout
immun
evalu
although
administr
live
kill
brv
mucos
site
intestin
mammari
region
induc
signific
elev
iga
igm
igg
antibodi
lacteal
secret
also
mark
increas
serum
antirotaviru
antibodi
determin
elisa
might
due
rapid
transmiss
viral
antigen
mucos
site
bodi
site
therefor
site
inocul
antigen
might
serv
portal
entri
could
also
due
spillov
mucos
produc
ig
circul
chang
et
al
promin
featur
studi
studi
employ
murin
model
halsey
et
al
increas
milk
antibodi
product
approxim
day
follow
parturit
increas
milk
ig
day
could
occur
result
product
antibodi
sensit
cell
resid
within
mammari
gland
turn
hormon
along
influx
antibodi
serum
halsey
et
al
shown
halsey
et
al
transfer
take
place
mous
much
milk
iga
fourth
day
lactat
come
serum
compar
eighth
day
rest
iga
like
produc
local
sensit
cell
mous
model
contrast
evid
local
product
iga
mammari
gland
earli
midlact
sheep
aj
husband
et
al
intern
congress
immunolog
toronto
canada
hanson
et
al
could
observ
transfer
dimer
iga
circulatori
system
milk
rat
bohl
saif
vaccin
pregnant
cow
via
imam
rout
live
attenu
transmiss
gastroenter
tge
viru
found
antibodi
milk
anim
primarili
igg
class
contrast
natur
infect
tge
viru
via
oral
rout
observ
antibodi
lacteal
secret
mainli
iga
class
bohl
et
al
thu
suggest
rout
infect
vaccin
viru
may
influenc
ig
class
secret
although
present
studi
major
antibodi
milk
igg
class
natur
infect
rotaviru
secretori
iga
close
relat
protect
mice
human
resist
degrad
trypsin
chymotrypsin
pepsin
offit
clark
reason
rel
higher
igm
titer
iga
lacteal
secret
clear
could
howev
reflect
primari
natur
immun
respons
rotavirusfre
mice
use
studi
also
case
imam
rout
immun
antigen
administ
intraderm
mammari
region
even
though
igm
igg
antibodi
predomin
lacteal
secret
effect
prevent
enter
infect
mice
question
newbi
sinc
iga
absorb
intestin
remain
local
therefor
effect
prevent
infect
compar
igg
igm
absorb
hanson
et
al
rat
mice
milk
antibodi
probabl
local
produc
sinc
mark
number
igcontain
cell
present
mammari
gland
late
pregnanc
parturit
lactat
involut
lee
et
al
thu
inocul
antigen
mammari
gland
rat
pregnanc
result
increas
specif
igcontain
cell
iga
igg
subtyp
lee
et
al
contrast
major
milk
ig
rumin
essenti
serumderiv
lactat
gland
contain
igcontain
cell
saif
smith
thu
physiolog
mammari
gland
specif
speci
immun
must
taken
consider
design
immun
protocol
control
enter
infect
neonat
result
studi
correl
work
oflit
clark
particularli
regard
antibodi
titer
serum
milk
follow
oral
immun
report
antirotaviru
antibodi
respons
serum
milk
even
homotyp
viru
approxim
gofold
lower
found
parenter
inocul
wherea
studi
differ
rout
immun
seem
make
differ
far
antibodi
titer
serum
milk
concern
plaqu
reduct
neutral
prn
titer
milk
particular
much
lower
log
oral
immun
compar
parenter
immun
offit
clark
even
though
one
would
expect
high
antibodi
titer
milk
immun
carri
use
mucos
versu
parenter
rout
explan
obviou
differ
given
author
whether
differ
studi
work
relat
differ
quantiti
qualiti
antigen
remain
determin
studi
requir
explor
possibl
factor
influenc
regul
lactogen
antibodi
respons
mice
anim
rotaviru
effect
control
measur
implement
studi
must
address
effect
hormon
neuropeptid
develop
immun
secret
ig
diamond
halsey
et
al
stanisz
et
al
weiszcarrington
recent
studi
clearli
indic
neuropeptid
modul
vitro
immun
respons
either
posit
neg
manner
furthermor
differ
antibodi
subtyp
may
alter
other
stanisz
et
al
intern
congress
immunolog
toronto
ontario
canada
studi
clearli
indic
potenti
regul
specif
lactogen
immun
respons
neuroimmunoregul
role
neuropeptid
hormon
regul
antirotaviru
lactogen
immun
present
investig
final
select
product
iga
antisuppressor
mechan
may
select
enhanc
iga
product
therebi
contribut
intestin
lactogen
immun
regul
ernst
et
al
intern
congress
immunolog
toronto
canada
understand
mechan
appropri
exploit
greatli
aid
enhanc
rotaviru
immun
neonat
newborn
thu
tremend
impact
morbid
mortal
due
rotaviru
infect
anim
human
